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A bstrac t
Quinacrine hydrochloride is being used in developing countries, like Vietnam 
and India, for transcervical female sterilization. There is much controversy re­
garding the carcinogenicity of this drug. Quinacrine intercalates with DNA and 
many intercalating agents are known to be mutagenic and therefore carcino­
genic. The results of previous mutagenicity testing of quinacrine in mammals 
are equivocal. This study uses the sister chromatid exchange test to evaluate 
the genotoxicity of two quinacrine compounds, quinacrine hydrochloride and 
quinacrine mustard. Sister chromatid exchange (SCE) is defined as the recip­
rocal exchange of DNA between two chromatids of a chromosome, presumably 
at identical loci. The occurrence of elevated SCE frequency indicates that ex­
posure to a DNA damaging agent has taken place. Results from this study 
show that SCE levels were not elevated in human peripheral lymphocytes ex­
posed in vitro to quinacrine hydrochloride or quinacrine mustard. Quinacrine 
hydrochloride also had no significant effect on the SCE levels of rat peripheral 
lymphocytes exposed in vivo even at several times the dose given to women 
during quinacrine sterilization. Ethylmethylsulfonate, a strong mutagen, was 
able to elevate SCE frequencies in these rat lymphocytes. It seems very un­
likely, therefore, that quinacrine is genotoxic in mammals. However, until long 
term studies can prove the safety and efficacy of this method, quinacrine ster­
ilization should be allowed to continue only as an experimental procedure in 
countries that are likely to benefit from it.
EVALUATING T H E  G EN O TO X IC IT Y  OF Q U IN A CRINE
IN MAMMALS 
USING T H E SISTER CHROM ATID EXCHANGE T E S T
Introduction
Quinacrine, a drug developed in the 1920s, was initially used to trea t m alaria  during 
World War II. It is a bright yellow crystalline powder (s truc ture  shown in Figure 1). 
While it was replaced by chloroquine for the trea tm en t of malaria, quinacrine was 
subsequently used to trea t tapeworm infections, giardiasis, and lupus and to control 
malignant effusions of the  pleural and peritoneal cavities. Its use as a sclerosing agent 
is what led investigators to look at its applicability as a tubal occlusion agent for non- 
surgical female sterilization. In the 1970s, a “slurry” of quinacrine was instilled into 
the  uterus for this purpose. Because of high failure rates, believed to be related to 
the  inability to contain the solution within the uterus, as well as concerns regarding 
leakage of the solution into the peritoneal cavity, a pellet form of the drug was de­
veloped. The pellet form appears to create a higher concentration of the drug within 
the  uterus for a prolonged period of time and is less likely to drain into the peritoneal 
cavity (Pollack Sz Garignan 1994).
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Figure 1: The s truc ture  of quinacrine hydrochloride. Chemically quinacrine is 6- 
chloro-9-(Tmethvl-4-diethylamine) butylamino-2-methoxyacridine, and it differs from 
chloroquine only in having an ex tra  benzene ring ra ther than  a quinolone (based on 
Steck EA: Chem otherapy of Protozoan Disease, vol III, pp 23-172. Walter Reed Army 
Ins titu te  of Research, US Government Printing Office, 1982.)
3Recently, the Vietnamese Health Ministry introduced quinacrine contraception 
in their sterilization programs. In 1989-92, nearly 32,000 women in V ie tnam  were 
sterilized using this form of contraception (Hieu et al. 1993). This m ethod involved 
transcervical in trau terine insertion of 252 mg quinacrine as pellets during the prolifer­
ative phase of the  m enstrual cycle. An IUD inserter is used to place seven cylindrical 
pellets into the uterus, each pellet containing 36 mg of quinacrine. The pellets dis­
solve and much of the quinacrine is either absorbed systemically or drains from the 
uterus through the cervix. However, enough remains in the uterus to cause inflamma­
tion and scarring of the intram ural portion of the tubes. To produce reliable scarring 
more than  one insertion is necessary. Two insertions at one m onth intervals is most 
successful (Zipper et al. 1993). Quinacrine sterilization became popular because it 
was a non-surgical procedure, could be performed by trained non-physicians, is very 
effective and extremely inexpensive. This method has an estim ated failure rate  of 2% 
after one year of use (Hieu et al. 1993).
The Indian Ministry of Health recently considered the introduction of quinacrine 
contraception for women into their family planning program. It has also been reported 
th a t private gynecologists in India have already been using quinacrine sterilization 
for some time (Kum ar 1995).
Quinacrine contraception in Vietnam  has, however, been halted by pressure from 
the W HO amidst much controversy over the carcinogenic potential of the drug. Cy­
togeneticists who use quinacrine for staining chromosomes (Q-banding) have always 
presumed quinacrine to be a potential carcinogen because it shows high-affinity b ind­
ing to nuclear and chromosomal DNA by intercalation between adjacent base pairs. 
Many intercalating agents are clastogens (chemicals tha t  induce physical damage to 
chromosomes). In turn , many clastogens are mutagens and /o r  carcinogens. T here ­
fore, women who have undergone quinacrine sterilization may be at an increased risk 
of developing fibrous uterine tumors or other neoplasia. This is naturally  an issue for
4concern. There  have been no long term  follow-up studies on any of these Vietnamese 
women for any such illnesses. However, there are reports of an apparent cluster of 
cancer cases found during long term  follow-up studies of Chilean women who were 
sterilized with quinacrine in the 1970s. Eight cases of cancer at a variety of sites were 
identified during the  long te rm  follow up of 572 women. These women had received 
two or three transcervical insertions of 250 mg of quinacrine hydrochloride between 
1977 and 1981 (Sokal et al. 1995).
Toxicity, teratogenicity, and mutagenicity studies with quinacrine were conducted 
in the late 1970s. Dubin et al. (19S3) performed intravascular, intrauterine, and in- 
traperitoneal instillation of quinacrine solution in cynomolgus monkeys. The studies 
indicated th a t  effects of the  drug are dose-related. Circulating drug levels s tim ulate  
the central nervous system, and very high levels lead to death  in these animal. Blake 
et al. (1983) tested  quinacrine in monkeis and rats for teratogenicity and m utagenic­
ity. A lthough the studies were limited by small sample size, in trauterine quinacrine 
appeared to have little  potential for inducing malformations bat was found to be em- 
bryolethal. Quinacrine is known to be a direct acting frameshift mutagen in bacterial 
systems (Ames and Whitfield 1966, Hoffmann et al. 1989). However, its im pact on 
m am m alian  cells is equivocal (see Table 1). Lym phocyte karyotypes of quinacrine 
trea ted  cynomolgus monkeys did not reveal chromosomal abnormalities (Blake et 
al. 1983). At least two studies on rodents have shown anticarcinogenic activity of 
quinacrine with respect to bladder and m am m ary cancer (K anam aru  et al. 19SS; 
M cCormick 1988).
No covincing evidence th a t  quinacrine causes cancer in humans has yet been pre­
sented. On the  contrary, carcinogenicity studies done by Family Health In ternational 
(FHI) in 1990 concluded tha t  “the lack of in vivo da ta  and, considering the extent of 
medicinal use, the  lack of relevant human data, suggests tha t  the risk for cancer may 
be quite sm all” (Tice, unpublished: cited in Hieu 1994). These studies were, however,
never published so the uncertain ty  surrounding the genotoxicity of this molecule still 
remains. This study is an investigation into the genotoxicity of quinacrine in vitro in 
hum an cells and in vivo in the rat system using the sister chromatid exchange assay. 
A review of the current litera ture  reveald tha t no such studies have ever been done 
on quinacrine using m am m alian test systems.
S is ter  ch ro m a tid  e x ch a n g e  (SCE) is the reciprocal exchange of DNA between 
two chromatids of a chromosome, presumably at identical loci. SCEs occur sponta­
neously in normal cells. SC'Es have been found in all eukaryotes in which they have 
been sought: in a variety of m ammals, including humans, in birds, fishes, insects and 
in plants. The baseline frequency of SCEs varies between individuals. Several papers 
have reported  a tendency to higher SCE levels in women than  in men (Morgan X 
Crossen 1977, Cohen et al. 1982, Husum et al. 1982, Livingston F inem an 1983, 
Wulf et al. 1986). Also, several authors have found higher SCE levels in older adults 
than  in younger adults  (Goh 1981, Schmidt <G Sanger 1981, Waksvik et al. 1981, 
Yakovenko X Platonova 1979 ). Race does not seem to affect the SCE level (B u t­
ler 1981). Lifestyle has been shown to influence SCE levels; smokers have increased 
baseline frequencies in their lymphocytes (Wulf 1990, N atara jan  1993).
It was originally thought tha t SCEs arose by breakage and reunion of sister chro­
m atids and were merely one class of ordinary chromosomal aberrations. But a pre­
ponderance of evidence suggests this is not so. For instance, chromosome breakage 
and rejoining occur after X-irradiation. SCEs however, are relatively insensitive to in­
duction by ionizing radiation and furthermore are not induced throughout the whole 
of the  cell cycle as are breakage induced aberrations (Wolff et al. 1984). The molec­
ular basis for SCE formation and therefore its biological and genetic significance is 
still unknown. It is known, however, tha t  maximal induction occurs at the s tart 
of S-phase and decreases progressively throughout the rest of S-phase (Sandberg X 
Block 1987). Two of the more plausible models proposed to explain the mechanisms
6for SCE formation are described below.
By far, the best model for SCE formation is the r e p l i c a t io n  b y p a s s  m o d e l  pro­
posed by Shafer (1977). The model (Fig. 2) suggests th a t  when normal bidirectional 
replication advances from both  directions toward a crosslink between the two parental 
strands with opposite polarity, the complementary parental s trand  segments can be 
tem porarily  displaced at each contralateral 5' side from the crosslink. T he free ends 
produced in this first step will be term inally  aligned but will have opposite polarity. 
The second step of the  bypass can, however, be completed by either of two rejoining 
processes: term inal ligation of the free ends via nascent Okazaki pieces or aberran t 
com plem entation by overlapping of the  free ends. This bypass mechanism  (1) allows 
replication to continue past a crosslink leaving the crosslink intact but (2) results 
in the switching of parental strands and their a ttached incomplete nascent strands 
above and below the crosslink site producing an exchange between sister chromatids.
In 1985, Saffhill and Ockey presented a s in g le  b r e a k  m o d e l  for SCE formation 
(Fig. 3). W hen DNA containing a single s trand  break is replicating, with or without 
an associated gap (excised bases) (Fig. 3a) the process continues normally until the 
replication fork reaches the region of a single s trand  break or gap (Fig. 3b). At this 
point in the case of the gap, the newly growing strand  using the complete tem plate  
can continue synthesis (Fig. 3c) and then ligate to the unreplicated end of the single 
s trand  break (Fig. 3d) assuming th a t  the strands have the correct polarity for this to 
occur. In the case of a break with no gap, only the ligation step would be required. 
Once this first strand exchange has taken place, further DNA synthesis cannot occur 
w ithout endonuclease incision. If this occurs in the tem pla te  s trand  w ithout the  break 
(Fig. 3e), the 5' end from the newly replicated DNA made on the other tem plate  
s trand  m ay then ligate with the  3' end of the break (Fig. 3f, g). Normal replication 
may then proceed (Fig. 3h) and give rise to an SCE in the  chromosome at the next 
mitosis (Fig. 3i).
O ther models include the replication detour model of Ishii and Bender (19S0) 
based on the  earlier work of Ivato (1974) tha t suggests tha t SCEs occur at the  repli­
cating fork of DNA and the postreplication model of SCE formation of Pain ter (1980) 
which proposes th a t  junctions between replication clusters are unstable sites prone 
to SCE formation.
A lthough equal SCEs may be difficult to observe on a molecular level, unequal 
SCEs, which result in the  duplication or deletion of particular sequences are easier to 
observe. Studies by Weinreb et al. (1990) have indicated the presence of left-handed 
Z-DNA and intramolecular triplex formation at the site of unequal sister chrom atid 
exchange.
High levels of SCE has been shown to occur in B loom ’s syndrome (BS) but not 
in o ther genetic diseases. BS is a rare autosomal recessive condition, characterized 
by short s ta ture , immunodeficiency, photosensitive skin lesions and an increased risk 
of developing all types of cancer. One of the characteristics oi BS is a high level 
of genomic instability, marked by chromosome breaks, gaps, translocations, a high 
frequency of both homologous chromatid exchanges and SCEs. all of which are con­
sistent with a defect in replication. Recently, the gene responsible for BS (6/m) was 
cloned by Ellis et al. (1995). The predicted BLM protein is homologous to recQ he- 
licase. It is possible th a t  loss of helicase activity generates abnormal DNA structures 
during replication which indirectly affects the activity of other DNA binding proteins 
or activates repair mechanisms (the la tter potentially accounting for the high rates 
of SCE). T he high levels of neoplasia of these subjects may possibly be related to the 
chromosomal changes, including the high SCE levels, seen in affected individuals.
T he sister chrom atid exchange assay was chosen to study the carcinogenicity of 
quinacrine because it is the most common and sensitive test system used to assess hu­
m an exposure to genotoxic compounds. Most agents th a t  cause chromosome breaks 
and many m utagens induce SCEs. .Thus, the occurrence of elevated SCE frequencies
sindicates th a t  exposure to a DNA damaging substance has taken place. SCE assays 
have therefore become a m ajor tool in mutagenesis research. T he frequency of sis­
te r chrom atid exchanges can be experimentally measured in cells grown in m edium  
containing 5-bromodeoxyuridine (see Fig. 4).
Typically, SCE tests are performed on peripheral blood lymphocytes. Normal 
(i.e., non-neoplastic) tissues used for cytogenetic studies have a very low m itotic  
index in vivo and thus require tissue culture prior to their use in cytogenetic studies. 
In culture, peripheral lymphocytes grow as free-floating cells w ithout attaching  to 
the  surface. External stim ulating factors (mitogens) need to be added to the  culture 
m edium  to induce cell division (mitosis). Phytohemagglutinin, an ex tract from red 
kidney beans, is a common mitogen. When sufficient cells have been cultured, a 
m ito tic  spindle inhibitor, like colcemid, is used to induce a block between m etaphase 
and anaphase. Cell division thus stops and metaphases accumulate to high frequencies 
(M oorhead et al. I960).
SCEs in somatic cells can be dem onstrated by differentially staining the two chro­
m atids of a m itotic  chromosome (Korenberg and Freedlender 1974, Perry and Wolff 
1974). This is achieved by incorporating a thymidine analog, bromodeoxvuridine 
(BrdU ), into replicating DNA for two successive cell cycles and subsequently sub jec t­
ing the chromosomal DNA to photodegradation. Sister chromatid differentiation can 
then  be visualized either by using one of the fluorochromes, Hoechst 33258 or DAPI, 
or by using Giemsa subsequent to photodegradation of BrdU. This sister chrom atid 
differentiation (SCD) is a result of the  bifiliarly B rdU -substitu ted  DNA strand  s ta in ­
ing faintly and the unifiliarly BrdU -substitu ted  DNA strand staining more intensely 
(see Fig 4). Cells th a t  have replicated for more than two cell cycles do not show 
SCD in all the  chromosomes, but may have (1) chromosomes with both chromatids 
faintly  stained, (2) chromosomes with a dark and a faint chromatid (similar to those 
seen at the end of the  second m etaphase in culture, or (3) chromosomes with a region
9th a t  has SCD while the remainder has both  chromatids lightly stained. Two basic 
mechanisms have been suggested for SCD: (1) the procedures used cause a greater 
loss of DNA from bifiliarly B rdU -substitu ted  chromatid than  from its counterpart 
with the  intensity of staining being proportional to the am ount of DNA remaining 
in the chromatid, and (2) the alteration in chromosomal proteins brought about by 
incorporation of BrdU into DNA in some way may influence the binding of Giemsa 
stain to chromosomes, resulting in differential staining. SCEs are analyzed by count­
ing the  num ber of exchanges as indicated by the discontinuity of intensely stained 
chrom atid in each cell. Each point of discontinuous staining is enum erated  as an ex­
change. Larger chromosomes usually have a greater num ber of SCEs than  do smaller 
ones. A chromosome may not have any SCEs whereas its homolog may show one or 
more SCEs in a given cell. Likewise, SCE incidence may vary from cell to cell (Verma 
& Babu 1995).
Sister chrom atid differentiation using BrdU yields chromosomes superior in resolu­
tion for the scoring of SCEs, and is technically much simpler to perform than  are other 
m ethods using radioactive nucleotides. Soon after its development, the new technique 
began to be used extensively for evaluating the mutagenic potential of several known 
carcinogens as well as new chemicals by comparing the SCE frequency induced by the 
test agent with the normal incidence (G ebhart 1981). Although a num ber of known 
clastogens (chemicals th a t  induce physical damage to chromosomes) produce an in­
creased frequency of SCE, a positive correlation is observed only in about 70% ol the 
test agents, with no such relation evident in the remaining agents. T he  disparity  is 
interesting; th a t  is, certain test agents elicited SCEs but not many s truc tu ra l chrom o­
some aberrations and vice versa. From these studies, it became evident th a t  SCEs and 
s truc tura l chromosome aberrations are different and independent expressions of m u­
tagen induced damage and probably signify different end results. For example, cells 
w ith s truc tu ra l aberrations are likely die after dividing whereas those with increased
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SCEs live. T he increased SCE frequency may however be positively correlated with 
higher m u ta tion  rates. In other words, induced SCEs are visible manifestations of the 
long te rm  m utagenic potential of the inducing agent. Regardless of the limitations of 
the SCE test, in light of the  many "false-positive” and “false-negative” results and 
the difficulty in in terpreting results owing to the  inadequate  understanding of the 
biological mechanisms of SCE, their enum eration can provide im portan t information 
regarding the m utagenic potential of chemical agents in our internal and external 
environments..
This s tudy  was divided into two phases - the first was comprised of in vitro studies 
with quinacrine (quinacrine hydrochloride and quinacrine m ustard) on hum an periph­
eral blood lymphocytes and the second of similar studies with quinacrine (quinacrine 
hydrochloride) perform ed in vivo in rats. Quinacrine m ustard  is another quinacrine 
compound also used in clinical cytogenetics as a chromosomal stain and is very sim­
ilar physically and chemically to quinacrine hydrochloride. It was hypothesized tha t  
if quinacrine was genotoxic then it would produce a significant elevation in the SCE 
frequency.
Specific questions th a t  this study a ttem pts  to answer are first, is quinacrine geno­
toxic to hum an cells in vitro? If so, what is the lowest dose tha t  can produce a 
significant increase in SCE level? Secondly, is quinacrine genotoxic in vivo in m am ­
mals? T he  la tte r  question was of interest because non-carcinogenic compounds are 
sometimes converted into carcinogens by enzymes (liver enzymes in particular) within 
the body and vice versa. It was expected tha t  the  outcome of these experiments would 
hopefully give some indication of whether quinacrine was safe to use as a contracep­
tive. Of course, further studies using other forms of m utagenicity testing would be 
needed before any m ajor decision regarding the continuation of quinacrine steriliza­
tion in V ie tnam  and other countries should be made.
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Table 1: M utagenicity tests with quinacrine in mammals
T E S T  S Y S T E M D R U G M E T H O D R E S U L T S R E F E R E N C E
R a t Q u in a cr in e  d iH C l 
160 m g /k g
D o m in a n t le th a l te st Eqi v o ca l, to o  few  
an im a ls
E p s te in  e t  al. 
1972
M o u se  sp er m Q u in a cr in e  d iH C l S core sp erm  h ea d  
a b n o rm a lit ie s
N e g a tiv e H ed d le  a n d  B ruce  
1 977
M o u se  p o ly c h r o ­
m a tic  e r y th r o ­
c y te s  o f  b o n e  
m arrow
Q u in a cr in e  d iH C l M icro n u cleu s a ssay  for  
ch ro m o so m e breakage
N eg a tiv e? H ed d le  a n d  B ruce  
1977
M o u se  b o n e  m ar­
row  e r y th r o c y te s
Q u in a cr in e  d iH C l 
0 .2 8  m g /k g
M icron u cle i P o sit iv e :  up  to  65%  
in crease  o f  m icro n u c le ­
a te d  e r y th r o c y te s
J essen  et  al. 1974
M o u se  b o n e  m ar­
row e r y th r o c y te s
Q u in a cr in e  d iH C l 
3 5 , 70 , 95 , 142 
m g /k g
M icron u cle i N e g a tiv e M a tte r  an d  
S ch m id  1975
C h in e se  h a m ste r  
ovary  ce lls
Q u in a cr in e  d iH C l 
5 / ig /m l  m ed iu m
D e te r m in in g  ce ll su r­
v iva l a fter  p reirrad ia­
t io n  a n d  p o stirra d ia ­
t io n  to  dru g
S e n s it iz e d  ce lls  to  
k illin g  by x-rays;  
g rea ter  e ffect w ith  
p re irra d ia tio n  e x p o ­
sure to  d ru g  m ay  
in h ib it  D N A  repair
V o icu le tz  et  al.  
1974
C h in e se  h a m ster  
ovary  ce lls
Q u in a cr in e  d iH C l 
0 .2  /iM , 2 /iM , 20  
AxM
S co r in g  ab n orm al 
a n a p h a se s  an d  chro­
m o so m a l breaks in  
m e ta p h a se s
F req u en cy  o f  ch rom o­
som e b reak age 3 to  5 
tim es th a t  o f  co n tro l 
(n o t co n sid er ed  h igh )
H su et  al. 1977
M o u se  L eu k em ic  
c e lls  L 1210
Q u in a cr in e  HC1 2 
/.ig /m l m ed iu m
S core ara  C J to ara C r 
ch a n g es
F req u en cy  re­
d u ced  5 to 16 fo ld  
“A nti m utagen ic"
B a ch  1969
R a t sa r co m a  
c e lls  (J e n se n )  
a sp a r a g in e
Q u in a cr in e  HC1
0 .01 /ig , 0.1  /ig ,
1 .0  /tg , 5 .0  / ig /m l
S co r in g  a sp -  to  a sp -*- 
co n v er ted  ce lls
In e ffec tiv e  in in crea s­
ing or d ecrea s in g  m u ta ­
t io n  freq u en cy
M orrow  et  al. 
1976
C y n o m o lg u s  m o n ­
k ey  p er ip h era l 
ly m p h o c y te s
Q u in a cr in e  HC1 
3 0 m g  in tr a u te r in e  
or in tr a v e n o u s
C h ro m o so m a l
a b n o r m a lit ie s
N e g a tiv e B lak e et  al.  1983
H u m a n  ste r n a l  
m arrow  ce lls  
( D -9 8 )
Q u in a cr in e  HC1 
0 .0 6  / ig /m l
S core a za g u a n in e  re­
s is ta n t  m u ta n ts
C u ltu res w ith  dru g  
c o n ta in e d  1/2 - 1 / 3  the  
m ean  o f  m u ta n ts  fou n d  
in co n tro l cu ltu r es
J o h n so n  a n d  B ach  
1969
H u m a n  p er ip h era l  
ly m p h o c y te s
Q u in a cr in e  HC1 
0 .3  g for 14 d a y s
T r ea ted  for p ro­
to z o a n  in fectio n  
k a ry o ty p e d  three  
tim es p re trea tm en t  
a n d  p o sttr e a tm e n t
N o a b n o r m a lit ie s  prior  
to  trea tm en t;  a fter  
trea tm en t m o d a l no. 
o f 48  ch ro m o so m es, 
a b n o rm a l m arker  
ch ro m o so m es







Figure 2: Replication crosslink bypass model of the sister chrom atid exchange (SCE) 
mechanism. Stage A: an interphase G l chromosome with an in te rs trand  crosslink 
(CL). Based on B rd U /S C E  staining methods, the thym idine retaining s trand  is 
shaded bu t the  BrdU substitu ted  s trand  is not. Stage B: bidirectional replication 
is in itia ted  above and below the crosslink. Stage C: the nascent s trands advance 
toward the crosslink. At this stage normal replication should be prevented by the 
crosslink. But replication could continue by bypassing the the crosslink if a two step 
d isplacem ent/re jo ining event (involving incision and /o r  ligation enzyme systems) oc­
curred. Displacement occurs at the stress points and, in Stage D, chain breaks are 
effected. In Stage E, after replication, the daughter duplexes form the two chromatids. 
T he  shaded s trand  segments containing thym idine are now separated into different 
chrom atids which results in the SCE staining effect. The crosslink, which remains in 
one chrom atid, may now be removed by repair (Shafer, 1977).
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3' 5' 3' S'
Figure 3: An a lternative  mechanism for SCE induction th a t  is in itiated  by the pres­
ence of a single s trand  break or gap associated with the  replication fork. Solid lines 
(thick and thin) represent parent (tem plate) strands and dashed lines (thick and thin) 
represent daughter strands: thick is synthesized on thick and thin on thin. S trand 
polarity is indicated by 3' and 5' (Saffhill and Ockey 1985).
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M -1: First metaphase after an S phase with BrdU 
M-2: Second metaphase after an S phase with BrdU 


















Figure 4: D iagram m atic  illustration of mechanism of sister chrom atid exchange visu­
alization by BrdU incorporation. Solid bars indicate the native DNA strand, whereas 
hatched  bars indicate  B rdU-incorporated DNA strand  (Verma and Babu 1995).
M aterials and M ethods
E x p e r i m e n t  1: E f fe c t  o f  v a r y in g  d o ses  o f  q u in a c r in e  h y d r o c h l o r i d e  a n d
q u i n a c r i n e  m u s t a r d  on  S C E  r a t e s  in h u m a n  p e r i p h e r a l  l y m p h o c y t e s  in
vitro
A heparinized blood sample (14 ml) was collected from a healthy 23 year old hum an 
female subject (non-smoker) from the brachial vein. 24 blood cultures, each con­
tain ing 0.5 ml whole blood, were initiated in 15 ml polystyrene graduated  centrifuge 
tubes containing 9.5 ml of prepared medium consisting of: R PM I 1640 supplem ented 
with 1% L-glutamine, 10% heat inactivated fetal bovine serum, 1% antibiotics and 
antimycotics, and 1.2% phytohem agglutinin (M form). All cultures were m ain ta ined  
at 37°C. One tube  contained only the blood and the culture media (this was to test 
the  quality of the  growth medium). Cultures 2-24 received 5 g g /m l of BrdU at 0 hrs 
of incubation. Tubes 2-6 were controls. Aqueous solutions of quinacrine hydrochlo­
ride were added to tubes 7-15 such tha t tubes 7-9 had a final concentration of 10~s 
M quinacrine hydrochloride, tubes 10-12 had 10~9 M quinacrine hydrochloride and 
tubes 13-15 had 10-1° M quinacrine hydrochloride. Aqueous solutions of quinacrine 
m ustard  were added to tubes 16-24 such tha t tubes 16-18 had 10-s  AI quinacrine 
m ustard , tubes 19-21 had 10-9 M quinacrine m ustard  and tubes 22-24 had 10_1° M 
quinacrine m ustard . At 70 hrs after culture initiation, 0.2 q g /m l colcemid was added 
to each culture. Cultures were harvested after an additional two hours. T he  lym ­
phocyte  harvesting procedure (Verma <C Babu 1995) entails centrifuging the cultures 
at 1200-1800 rpm  in a s tandard  benchtop centrifuge for 5 minutes, p ipe tting  off the 
su perna tan t followed by hypotonic trea tm ent with 8 ml of 0.075 Al KC1 for 10 m in­
utes (so th a t  the RBC burst and the lymphocytes swell) and finally fixing in freshly 
p repared 3:1 m ethanokacetic  acid fixative overnight. Several washings of fixative are 
often needed until the  cultures become clear of hemoglobin and red cell debris.
For m aking slides, fixed cells are centrifuged and the supernatan t is discarded. A
15
16
small am ount of fresh fixative is added and the cells are resuspended with a Pasteur 
pipette . Four to five drops of this cell suspension are dropped onto clean wet slides 
which are air dried and then stained for sister chrom atid differentiation by the  Giemsa 
staining procedure. In the  staining procedure the  slides are trea ted  with Hoechst 
3325S solution (150 f ig /ml) at room tem peratu re  and kept in the  dark for 10-15 
minutes. Hoechst 33258 has a greater affinity for bifiliarly BrdU substi tu ted  DNA 
and increases sensitivity of DNA to UV damage. Slides are exposed to UV light for 1-2 
h in 2X SSC followed by incubation at 60-65°C for another 1-2 h again in 2X SSC. This 
washes away the fragments of DNA broken by the UV light. Slides are then rinsed 
in distilled water, allowed to air dry and subsequently stained in 2% Giemsa for 5-6 
minutes. After slides are rinsed in tap water to remove excess stain and are dried, SCE 
scoring can begin. W hen scanning slides, dividing cells in their second m etaphase can 
be identified by their half dark and half light appearance as “harlequin chromosomes". 
At the second metaphase, only one chromatid has BrdU incorporated into both single 
strands and most of the DNA in tha t s trand  was removed during UV exposure and 
incubation. T h a t  chrom atid  subsequently stains lightly with Giemsa while the other 
chrom atid stains darkly. Sister chromatid exchange can therefore be easily detected 
wherever there is exchange of light and dark m aterial on the chromosomes. For each 
trea tm en t group 100 cells were scored. An Olympus BH-2 microscope was used. 
Slides were scored at 600X and 1000X magnifications. Photographs of typical cells 
were taken at 1000X magnification.
E x p e r i m e n t  2: E f fe c t  o f  v a r y in g  d o ses  of q u in a c r in e  h y d r o c h lo r id e  on  S C E  
r a t e s  in  r a t  p e r i p h e r a l  l y m p h o c y t e s  in vivo
Seven young adult female albino Sprague-Dawley rats weighing between 200-250 g 
were obtained and placed into separate  cages where they were m aintained under 
s tandard  laboratory  care for one week prior to the  s tar t  of the experim ent. Five 
rats received different doses of quinacrine hydrochloride (250 m g/kg, 200 m g/kg , 125
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m g/kg , 62 m g /kg  and 1.5 m g/kg  body weight), one was a positive control (lOOmg/kg 
body weight of ethylmethylsulfonate, a strong mutagen) and one was used as a neg­
ative control (placebo of physiological saline). All drugs were dissolved in physio­
logical saline and adm inistered intraperitoneally. These particular doses were chosen 
because: (a) In rats, the maximal tolerable dose was reported to be 250 m g /k g  fol­
lowing in traperitoneal adm inistration. Doses higher than  this are lethal (Dubin et al. 
1983). To maximize our probability of detecting genotoxicity, one level of trea tm en t 
needed to be at the  m axim um  tolerable dose, (b) In order to study  dosage effects of 
quinacrine, if any, we administered one half and one quarter of the  m axim um  tolerable 
close as well, (c) The 1.5 m g/kg  body weight of quinacrine was the  estim ated  level of 
quinacrine achieved in a w om an’s body after sterilization with three insertions taking 
into consideration th a t  some is lost through the vagina and the rest is being elimi­
na ted  (biological half life of 7 days in monkeys, Dubin et al. 1983). Sprague-Dawley 
rats are a highly inbred, and therefore genetically homogeneous, strain. We therefore 
considered one animal per trea tm en t to be appropriate.
Following the protocol for in vivo genotoxicity testing by the SCE m ethod of 
Ivligerman et al. (1981), blood was collected four days after adm inistra tion  of the 
drugs. This tim e interval allows sufficient time for damage, if any, to occur within the 
DNA of the lymphocytes without giving sufficient time for either the complete repair 
of these lesions before DNA replication, or for significant lym phocyte turnover after 
clearance of the quinacrine. Heparinized blood samples (3 to 5 ml) were collected 
by cardiac puncture  after carbon dioxide asphyxiation. Whole blood cultures (0.5 
ml b lood /cu ltu re)  were established in T-25 tissue flasks containing 5 ml of prepared 
media: R PM I 1640 supplem ented with 1% L-glutamine, 20% heat inactivated fetal 
bovine serum, 1% antibiotics and antimycotics and 2% of the highly purified P-form 
of phytohem agglutin in  (Sinha et al. 1988). BrdU concentrations, culture, harvest 
and slide p reparation  protocols were identical to those used in experim ent 1. For
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each trea tm en t group, 60 cells were scored.
S ta t is t ic a l  an a ly s is
T he  sister chrom atid  exchange frequency da ta  was analyzed by one way analysis of 
variance to determ ine if any groups differed significantly (a= 0 .05) from the others. 
Since the  d a ta  was discontinuous, with unequal deviations and did not follow a normal 
d is tribu tion  the  non-param etric  Ivruskal-Wallis one way ANOVA was used. A Tukey 
a posteriori  test was also done to determine which groups were significantly different 
from which others.
R esu lts
To test the  genotoxic effects of quinacrine in humans, the frequency of SCEs in periph­
eral lym phocytes was measured after in vitro trea tm en t with three doses of quinacrine 
hydrochloride or quinacrine m ustard . BrdU was added immediately  after trea tm en t 
w ith the  quinacrine compounds. No significant variation in SCE frequencies was ob­
served for e ither of the two quinacrine compounds tested (Table 1, Fig. 5). S ta tistical 
analysis of the  d a ta  on all 7 trea tm en ts  revealed th a t  the  probability th a t  deviations 
from the null hypothesis as great as or greater than  those observed would occur by 
chance alone was 0.38. The non-significant variation in SCE frequencies observed for 
10-8 M, 10-9 M and 10_1° M concentrations of quinacrine hydrochloride or m ustard  
did not show any dose response.
The second experiment was designed to determ ine if quinacrine shows in vivo 
genotoxicity in m ammals as a result of in vivo modification by enzymes. Initially, 4 
rats were trea ted  with various doses of quinacrine hydrochloride or 100 m g /kg  body 
weight of e thylm ethylsulfonate (EMS), the positive control, or physiological saline, the 
negative control. The rats th a t  were administered 250 m g/kg  and 200 m g /kg  doses 
of quinacrine hydrochloride died within hours. Lymphocytes from the the remaining 
animals were cultured and, as before, SCE frequency was measured. Quinacrine was 
found to have no effect on SCE frequency (p=0.65) (Table 2, Fig. 6). Elowever, as 
expected, EMS was found to cause a significant increase in SCE frequency. Statistical 
analysis of the  EMS d a ta  showed tha t the probability of the observed difference 
difference arose from chance alone was less than  10~3. Using an a  value of 0.05 this 
difference is highly significant. Again, the non-significant differences in SCE frequency 
between the 125 m g/kg, 62 m g/kg  and 1.5 m g/kg  quinacrine hydrochloride trea tm en t 
groups and control did not suggest a dose response relationship.
Representative cells showing SCEs are shown in Figures 7 and 8. In the in vitro ex­
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perim ent 100 cells were scored from each trea tm en t group. It was necessary to keep 
sample sizes the same because this was a requirem ent for the s tatistical technique 
used. In the  in vivo experim ent, however, the num ber of second division m etaphases 
scored in each trea tm en t group was reduced to 60. The reason for this was the  cyto­
toxic effect of the  100 m g/kg  EMS. Slides prepared using EMS-exposed lymphocytes 
showed highly reduced numbers of both dividing and interphase nuclei as compared 
to control and quinacrine-exposed lymphocytes slides. The concentration of ethyl- 
methylsulfonate used in this experiment thus became the factor limiting sample size.
Table 2: T he effect of varying quinacrine hydrochloride (Q H Cl)and quinacrine m us­
tard  (QM) concentrations on SCE frequencies in hum an lymphocytes exposed in vitro
Treatment Cells scored Mean SCE/cella Standard deviation Standard error
Control6 100 7.73 3.72 0.37
10~loM QHC1 100 8.25 4.06 0.41
10~9M QHC1 100 7.90 3.69 0.37
1CT8M QHC1 100 8.72 3.60 0.36
10_1UM QM 100 8.41 3.63 0.36
10- 9 M QM 100 8.38 4.26 0.43
1CTSM QM 100 8.72 4.03 0.40
a M ean S C E  frequencies were not significantly altered  by quinacrine  HC1 or m u s ta rd  (c*=0.05) 
b W ater
Table 3: T he effect of varying quinacrine hydrochloride (QHCl)concentrations on 
SCE frequencies of ra t  lymphocytes exposed in vivo
Treatment Cells scored Mean SCE/cella Standard deviation Standard error
Control6 60 8.07 2.93 0.38







125 m g/kg  QHC1 60 7.22 3.52 0.45
62 m g/kg  QHC1 60 7.82 3.33 0.43
1.5 m g/kg  QIIC1 60 7.82 2.96 0.38
a M ean S C E  frequencies were not s ignificantly altered by quinacrine  hydrochloride (£*=0.05) 
^Negative control (physiological saline) 
cPositive control
^Increase in S C E  frequencies produced by EMS was highly significant ( p < 1 0 ~ 3 , a  =  0.05)
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Quinacrine hydrochloride 
□  Quinacrine mustard
Figure 5: Effect of varying quinacrine hydrochloride and quinacrine m ustard  concen­
tra tions on SCE frequencies of PHA -stim ulated hum an lymphocytes cultured for 72 
hours. Each point represents the mean ±  SE from the in vitro experiment. Quinacrine 
was not found to have any significant effect on SCE frequencies.
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Control EM S Q uinacrine Q uinacrine  Quinacrine
lOOmg/kg 1.5mg/kg 62m g/kg  125mg/kg
Figure 6: Effect of varying quinacrine hydrochloride and concentrations on SCE fre­
quencies of PH A -stim ula ted  rat lymphocytes cultured for 72 hours. Each bar rep­
resents the  m ean d= SE from the in vivo experiment. Quinacrine was not found to 
have any significant effect on SCE frequencies. E thylm ethylsulfonate was used as a 
positive control and increased SCE frequencies significantly.
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Figure 7: H um an lym phocyte metaphases showing sister chromatid differentiation by 
Giemsa. A num ber of sister chrom atid exchanges (SCEs) are present in each of these 
cells (a, b, c and d). a: a cell with 8 SCEs; b: a cell with 9 SCEs; c: a cell w ith 5 
SCEs; d: a cell with 10 SCEs. An SCE is shown by the arrow.
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Figure S: R at lymphocyte metaphases showing sister chromatic! differentiation by 
Giemsa. A num ber of sister chrom atid exchanges (SCEs) are present in each of these 
cells (a, b, c and d).a: a cell with 5 SCEs; b: a cell with 9 SCEs; c: a cell with 9 
SCEs; d: a cell with 17 SCEs. An SCE is shown by the arrow.
D iscussion
The prim ary  function of this study  was to investigate w hether quinacrine increases 
the  frequency of sister .chromatid exchanges in m am m alian  cells in vivo. From the 
d a ta  obtained, it appears th a t  quinacrine has no effect on SCE frequencies in hum an 
and ra t peripheral lymphocytes. This conclusion is ra ther surprising in the light of all 
its biological properties, although, not all together unexpected because some evidence 
of its lack of clastogenicity and mutagenicity does exist (Bach 1969, Heddle & Bruce 
1977, M atte r  M Schmid 1975, Morrow et al. 1976).
Quinacrine hydrochloride and quinacrine m ustard, the  two compounds studied, 
are acridine derivatives. In tercalation in the DNA helix is a common element in the 
genetic activity  of acridine compounds (Hoffman et al. 1989). Acridine mustards, 
like quinacrine m usta rd , however, have additional groups on the acridine ring system 
tha t bring about covalent binding to DNA. The genetic effects of these reactive inter- 
calators are therefore a function of both adduct formation and intercalation or base 
displacement. In contrast, o ther acridines such as quinacrine, do not react covalently 
with DNA, and their genetic effects can be ascribed to simple intercalation between 
adjacent base pairs (Nasim & Brychcy 1979). The generalization th a t  the principle 
genetic effect of acridines is the  induction of frame shift m uta tions  seems to apply in 
a broad range of organisms and systems (Hoffman et al. 1989). Quinacrine m ustard  
has also been shown to be an alkylating agent (Kohn et al. 1987).
Among its o ther biological activities, quinacrine inhibits the activity of phospholi- 
pase A 2 in several experim ental model systems (Vargaftig Sz Hai 1972, Blackwell et al. 
1978). This inhibition limits the production of arachidonic acid from m em brane phos­
pholipids, thereby reducing the am ount of substrate  available for further m etabolism  
through the cycloxygenase or lipoxygenase pathways. Like o ther inhibitors of these 
pathways of arachidonic acid metabolism, quinacrine also has protective activity
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against m am m ary  carcinogenesis in rats. However, the chemopreventive activity  of 
quinacrine is limited by its toxicity at higher doses (McCormick 19SS).
Quinacrine hydrochloride is also a DNA repair inhibitor (Popanda Sz Thielm ann 
1992). Inhibition by this in tercalating agent seems to be caused by s truc tu ra l  p e r tu r ­
bations in DNA, which render it a poor substrate  for endonucleolytic cleavage (Thiel­
m ann  et al. 1991). Interestingly, quinacrine is a weak inhibitor of topoisomerase II - 
an enzyme thought to be involved in DNA repair (Thielm ann et al. 1993).
Sister chrom atid exchange d a ta  from this study, however, does not provide evi­
dence th a t  quinacrine is genotoxic. If the  quinacrine compounds had produced any 
unrepaired damage to the  DNA such as breaks, adducts, crosslinks etc., these would 
have resulted in an increase in frequency of SCEs. The occurrence of SCEs in the 
observed cells dem onstrates th a t  the procedure for SCE visualization was successful. 
Also, in the  in vivo experim ent, EMS, the known mutagen, did significantly increase 
SCE frequency. This suggests th a t  if quinacrine did increase SCE frequency in vivo it 
would have been detected by this test. Although BrdU may be responsible for part of 
the  baseline frequency, it has been shown tha t spontaneous SCE may actually  exist. 
T he  baseline frequency apparently  also depends on the DNA content ra the r than  on 
the chromosome num ber of the respective m ammalian species (Ivato et al. 1977). In 
the  case of hum ans and rats, the  two species employed in the current study, both  
values are similar. Rats have 42 chromosomes and approxim ately 5.7 pg of D N A /cell 
while hum ans have 46 chromosomes and 6 pg of DNA/cell (Swanson et al. 1981). 
The estim ated  baseline SCE levels in rats is between 8-10 SCEs/cell (Kligerman et 
al. 1981, Sinha et al. 1988) and in humans it is 6-8 SCEs/cell (G ebhart 1981). The 
observed baseline frequency for the hum an subject in this study was 7.73 SCEs/cell 
and fell within the  normal range. The observed baseline frequency for the  rats used 
in the  in vivo experim ent was 8.07 SCEs/cell and this too is normal for the  species. 
None of the  various concentrations of quinacrine hydrochloride used in the  in vitro
or in vivo experiments increased the SCE frequency significantly. Even quinacrine 
m ustard , the other quinacrine compound tested, showed no significant effect on the 
baseline SCE frequency of the m am m alian cells studied. The highest concentration 
of quinacrine tested  in vitro (10_SM) was the highest concentration th a t  could be 
achieved in cell cultures w ithout cytotoxic effects. In the  in vivo experim ent the ani­
mals trea ted  with the  higher doses of quinacrine hydrochloride (250 m g/kg  and 200 
m g/kg) unfortunate ly  died, presumably due to the toxicity of this compound.
In any case, even a dose of 125 m g/kg  quinacrine, which is many times the  m axi­
m um  dose given to women during sterilization, produced no observable genotoxicity 
in the  form of elevated SCE frequencies. Even in the worst case scenario, if a woman 
receives 3 insertions, a to ta l of approximately 750 mg of quinacrine hydrochloride 
and all of this is absorbed, this amounts to approximately 15 m g/kg  concentration of 
quinacrine in her body. In a real situation, however, some of the quinacrine drains out 
through the woman's vagina (Sokal et al. 1995). Most of the rem ainder is absorbed 
systemically but due to the short elimination half-life of quinacrine, approxim ately  7 
days (Dubin et cd. 19S3), the m axim um  concentration th a t  is likely to be ever achieved 
in the blood is probably closer to the lowest dose tested in this study i.e., 1.5 m g/kg  
quinacrine hydrochloride. Thus, from the results of the  SCE test, it appears tha t  
quinacrine does not damage DNA at non-toxic levels. It is, therefore, not very likely 
th a t  it has high m utagenic potential and may not be even mildly carcinogenic.
These results, however, contradict those previous study by Vogel and Friebe 
(1987,) which reported  quinacrine m ustard to increase the SCE frequency of Vicia 
faba root tip  cells by a factor of four. Considering the very large genome size of Vicia 
faba , which contains approxim ately 42 pg DNA, i.e., seven times the size of the  hum an 
genome (Swanson et al. 1981), it is probably a much more sensitive system. T he  rel­
evance of this data , to the safety of quinacrine use in humans is questionable because 
it was generated in plants. Differences in metabolism may have led to the  conversion
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of quinacrine into a more harmful form in the plant an d /o r  to i t ’s conversion into 
a less harm ful form in mammals. Also, Vicia faba chromatids are of much greater 
d iam eter than  m am m alian  chromatids which could indicate a difference in packaging 
of the  DNA. If indeed such a difference in packaging does exist, this could perhaps 
result in quinacrine being able to intercalate  more easily with Vicia faba DNA.
Bennet et al. (1987) have shown quinacrine to have little or no effect on metastasis, 
response to chemotherapy, tum or size or tum or prostanoid1 formation. McCormick 
(19SS) has even shown anticarcinogenic activity  of quinacrine in the  ra t m am m ary  
gland. These findings are consistent with the results of this study.
A recent report by Sokal et al. (1995) evaluated the  cancer incidence among 
women sterilized with transcervical quinacrine hydrochloride pellets between 1977 
and 1991 in Chile. Medical histories of 1,492 women sterilized with quinacrine were 
analyzed. The occurrence of an unusual cluster of cancers (8 in a cohort of 572 
quinacrine sterilized women) was confirmed, bu t no evidence was found of excess 
cancer risk associated with quinacrine pellet sterilization. However, there was a sin­
gle provocative observation, a uterine leiomyosarcoma (cancer of the sm ooth m us­
cle). B ladder leiomyosarcomas have occurred in humans after exposure to cyclophos­
pham ide, a drug th a t  forms covalent bonds with DNA. Relevant to this observation 
on quinacrine, Nasim and Brychcy (1979) noted th a t  “Up until now, only those chem­
icals th a t  in teract covalently with DNA have been shown to be both  m utagens and 
carcinogens. As acridines (including quinacrine) belong to a class of compounds which 
in tercalate  DNA and do not bind covalently, it is therefore of m ajor im portance  tha t 
fu r ther investigation be carried ou t .”
T he  probability th a t  in trau terine  quinacrine is a factor in hum an carcinogenesis 
is difficult to assess. On the one hand, the  low' dose and brief exposure would suggest 
there is little likelihood of any significant risk, on the other hand, the  unique mode
P r o s t a g l a n d i n  derivatives
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of adm inistra tion, high local concentration and associated cytotoxicity are possible 
reasons for concern. In the mouse, it is possible to produce cervical cancers with 
the  vaginal instillation of chemical carcinogens (Das et al. 1993). This may be a 
fu ture  direction one would like to follow to directly ascertain the carcinogenicity of 
quinacrine sterilization. T he retrospective study  by Sokal’s group in Chile continues 
and at least ano ther five years of d a ta  is expected to be collected (Sokal et al. 1995). In 
Vietnam , Family H ealth  In ternational, in collaboration with Vietnamese authorities, 
is planning to in itia te  another long term  follow up study of a group of women who 
were sterilized with quinacrine (Hieu et al 1993).
Quinacrine has been an approved drug for m any years and its oral use has been 
advocated in the  United States as a “steroid-sparing” anti-inflam m atory agent in 
the  trea tm en t of rheum atic  diseases (Wallace 1989) and, until recently, it was sold 
under the nam e of “A tabrine” by Sanofi W inthrop Pharm aceuticals  as chemotherapy 
for giardiasis, tapew orm  and m alaria  (PD R, 1994). Women receiving quinacrine for 
sterilization are exposed to to ta l doses of only approxim ately 500 mg (two insertions) 
or 750 mg (three insertions), while quinacrine was used in much higher dosages for 
the prophylaxis and trea tm en t of m alaria  during World War II. Soldiers took oral 
doses of 100 to 200 m g /d ,  i.e., >  36 g /y r  (Condon-Rail 1991). It would seem th a t a 
systemic carcinogenic effect would have been more likely to appear in World War II 
veterans who took prophylactic  quinacrine than  among women receiving quinacrine 
for sterilization. A lthough studies of exposed servicemen at the tim e did reveal the 
rare occurrence of a dose related marrow aplasia (Custer 1946), there  apparently  were 
no long te rm  follow up studies tha t  specifically addressed the  issue of carcinogenicity.
Past testing has shown th a t  quinacrine is mutagenic in some systems but it has not 
been evaluated according to current FDA standards. A study of the chronic toxicity of 
quinacrine in rats  was done in the 1940s by the FDA itself, and the authors concluded 
th a t  quinacrine was not a carcinogen (Fitzhugh et al. 1945), but th a t  study was not
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conducted according to current s tandards and the drug was adm inistered orally ra ther 
than  transcervically.
I have tried to evaluate the mutagenic potential of quinacrine using both  an in 
vitro hum an and in vivo ra t model to simulate a situation which could be relevant 
to the  hum an in vivo exposure. The data  generated from this s tudy  is therefore 
relevant. The  SCE assay has been approved by the W HO and EPA as a highly sen­
sitive m utagenicity  test. The negative results from this study, combined with the 
fact th a t  quinacrine does not cause chromosomal aberrations, makes it less likely 
th a t  quinacrine is a m utagen in m am m alian systems. However, any risk of carcino­
genicity, no m a tte r  how small, would make it difficult to license quinacrine for female 
sterilization in the  United States because of the very low risk of readily available sur­
gical alternatives. Even if it were approved by the U.S. FDA, quinacrine sterilization 
would probably not become widely used in the United States because of its relatively 
low effectiveness compared with surgery (Sokal et al. 1995). Nonetheless, quinacrine 
sterilization could be useful for women with a contraindication or fear of surgery or 
in developing countries where the availability and safety of surgical sterilization are 
often less than  in developed countries. In fact, studies of surgical sterilization in 
developing countries report death  rates of 19-99 per 100,000 cases (Rosenberg et al. 
1982, B h a t t  1991). If the questions regarding safety and efficacy of this m ethod  of 
sterilization can be satisfactorily answered by this and other studies, the low cost and 
ease of insertion would make quinacrine a promising m ethod for areas of the  world 
where m aternal m ortality  is high, access and availability of family planning resources 
are low, and unm et demand for perm anent methods is great. However, additional, 
carefully designed studies tha t  specifically address long-term safety are needed. Un­
til rem aining questions have been answered, the use of quinacrine pellets for female 
sterilization should continue to be considered an experimental procedure.
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